Skip to content
TrialScanner

NCT04838444

Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)

Phase 3Active, not recruitingVALNLead

Registry record

Lead sponsor
Valneva Austria GmbH
Conditions
Chikungunya Virus Infection
Primary completion
Mar 3, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04838444 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04838444: Antibody Persistence And... | TrialScanner